Gaia Andreoletti

机构：Sage Bionetworks, Astellas Pharma (Japan) · ORCID：0000-0002-0452-0009

发表论文 100 篇 · 总被引 1388 次 · h-index 20

代表论文

• CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods (2024 · Genome biology · 被引 63)
• Critical assessment of missense variant effect predictors on disease-relevant variant data (2025 · Human Genetics · 被引 26)
• Critical assessment of missense variant effect predictors on disease-relevant variant data (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 9)
• A differentiated β-globin gene replacement strategy uses heterologous introns to restore physiological expression (2025 · Molecular Therapy · 被引 8)
• Functional screening in human HSPCs identifies optimized protein-based enhancers of Homology Directed Repair (2024 · Nature Communications · 被引 7)
• VMAP: Vaginal Microbiome Atlas during Pregnancy (2024 · JAMIA Open · 被引 5)